IMAB
$1.23
Revenue | $1542.67Mn |
Net Profits | $1041.55Mn |
Net Profit Margins | 67.52% |
I-mab’s revenue jumped 5042.23% since last year same period to $1542.67Mn in the Q4 2020. On a quarterly growth basis, I-mab has generated +Inf% jump in its revenue since last 3-months.
I-mab’s net profit jumped 398.81% since last year same period to $1041.55Mn in the Q4 2020. On a quarterly growth basis, I-mab has generated 8424.72% jump in its net profits since last 3-months.
I-mab’s net profit margin jumped 105.81% since last year same period to 67.52% in the Q4 2020. On a quarterly growth basis, I-mab has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Year | -0.14 |
I-mab’s earning per share (EPS) estimates for the current year stand at -0.14.
Earning Per Share (EPS) | 0 |
I-mab’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the I-mab has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-01 | -0.47 | 0 | 100% |
2023-11-29 | -0.14 | 0 | 100% |